FDA Offers 'Rapid' Help As Stem Cell Approval Deadline Nears

By Jeff Overley (June 12, 2019, 8:54 PM EDT) -- The U.S. Food and Drug Administration on Wednesday offered to give "rapid" feedback to stem cell clinics that solicit its views on how their treatments would be regulated in an effort to jump-start inquiries by clinics that have largely ignored an approaching deadline to seek agency approval....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!